GB2144738A - Imidazolines - Google Patents

Imidazolines Download PDF

Info

Publication number
GB2144738A
GB2144738A GB08321719A GB8321719A GB2144738A GB 2144738 A GB2144738 A GB 2144738A GB 08321719 A GB08321719 A GB 08321719A GB 8321719 A GB8321719 A GB 8321719A GB 2144738 A GB2144738 A GB 2144738A
Authority
GB
United Kingdom
Prior art keywords
phenyl
compound
pharmaceutically acceptable
acid addition
addition salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB08321719A
Other languages
English (en)
Other versions
GB8321719D0 (en
Inventor
Kazuo Matsumoto
Yoshio Iwasawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Priority to GB08321719A priority Critical patent/GB2144738A/en
Publication of GB8321719D0 publication Critical patent/GB8321719D0/en
Priority to JP59164160A priority patent/JPS6051176A/ja
Publication of GB2144738A publication Critical patent/GB2144738A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB08321719A 1983-08-12 1983-08-12 Imidazolines Withdrawn GB2144738A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB08321719A GB2144738A (en) 1983-08-12 1983-08-12 Imidazolines
JP59164160A JPS6051176A (ja) 1983-08-12 1984-08-03 新規イミダゾリン誘導体及びその製法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08321719A GB2144738A (en) 1983-08-12 1983-08-12 Imidazolines

Publications (2)

Publication Number Publication Date
GB8321719D0 GB8321719D0 (en) 1983-09-14
GB2144738A true GB2144738A (en) 1985-03-13

Family

ID=10547197

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08321719A Withdrawn GB2144738A (en) 1983-08-12 1983-08-12 Imidazolines

Country Status (2)

Country Link
JP (1) JPS6051176A (https=)
GB (1) GB2144738A (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07111812B2 (ja) * 1987-06-15 1995-11-29 三菱電機株式会社 デイジタル再生装置
JPH0748285B2 (ja) * 1986-10-24 1995-05-24 三菱電機株式会社 ディジタル再生装置

Also Published As

Publication number Publication date
GB8321719D0 (en) 1983-09-14
JPH0542432B2 (https=) 1993-06-28
JPS6051176A (ja) 1985-03-22

Similar Documents

Publication Publication Date Title
USRE33024E (en) Bronchodilating 8-hydroxy-5-(1R)-1-hydroxy-2-(N-((1R)-2-(p-methoxyphenyl)-1-methylethyl)-amino)ethyl) carbostyril and intermediates thereof
RU2005721C1 (ru) Способ получения 3-хинуклидинилпропаноатов
EP0289227B1 (en) Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
US6410582B1 (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
JPH0587504B2 (https=)
HU202211B (en) Process for producing new imidazoline derivatives and pharmaceutical compositions containing them as active components
US4575508A (en) 2-Substituted 1-(3'-aminoalkyl)-1,2,3,4-tetrahydro-β-carbolines, and their use as antiarrhythmic agents
IE913175A1 (en) Aryl-fused and hetaryl-fused-2, 4-diazepine and 2,¹4-diazocine antiarrhythmic agents
JPH02178263A (ja) アザアズレン誘導体、その製造法およびそれを有効成分とする抗アレルギー剤および抗炎症剤
GB2144738A (en) Imidazolines
JPH02268172A (ja) 新規なベンズオキサゾリノン誘導体
JPS63264445A (ja) 新規のインダン誘導体、その製造方法及び薬剤としてのその使用
US4363816A (en) Tricyclic pyrroles, their compositions and their use
JP2753591B2 (ja) インダンから誘導される化合物の薬剤としての使用並びにそれらを含有する製薬組成物
KR100382998B1 (ko) 6-메톡시-1h-벤조트리아졸-5-카르복사미드유도체,그제조방법및그것을함유하는의약조성물
US4758566A (en) 2-(1-piperazinyl)-4-substituted phenylquinoline derivatives, processes for the preparation thereof, and pharmaceutical composition containing the same
JPH069402A (ja) 抗潰瘍剤
KR0149066B1 (ko) 시클로헥산 유도체
RU2142453C1 (ru) ПРОИЗВОДНЫЕ 1-[ω-(3,4-ДИГИДРО-2-НАФТАЛИНИЛ)АЛКИЛ]ЦИКЛИЧЕСКОГО АМИНА И СОДЕРЖАЩАЯ ИХ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
JPS6345667B2 (https=)
JPH09241241A (ja) Ｎ−（１−置換−４−ピペリジル）ベンズアミド誘導体
JP2592276B2 (ja) １，５ーベンゾチアゼピン誘導体、排尿障害治療剤及びその製法
JP3504972B2 (ja) ２−［２−（置換アミノ）ベンジルチオ］−５，６，７，８−テトラヒドロピリド［３，４−ｄ］ピリミジン−４（３Ｈ）−オン誘導体
NO840241L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-((fenetyl)-5-((3,4-metylendioksy)-alfa-hydroksylbenzyl)pyrrolidiner
US4024259A (en) 3-Anilino-2,4-diazabicyclo[3.2.1]octenes

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)